BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36414640)

  • 21. Regulation of lung fibroblast activation by annexin A1.
    Jia Y; Morand EF; Song W; Cheng Q; Stewart A; Yang YH
    J Cell Physiol; 2013 Feb; 228(2):476-84. PubMed ID: 22777765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression.
    Tang Y; Jiang L; Zhao X; Hu D; Zhao G; Luo S; Du X; Tang W
    Cell Biol Int; 2021 Dec; 45(12):2510-2520. PubMed ID: 34459063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling.
    Bena S; Brancaleone V; Wang JM; Perretti M; Flower RJ
    J Biol Chem; 2012 Jul; 287(29):24690-7. PubMed ID: 22610094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylprednisolone up-regulates annexin A1 (ANXA1) to inhibit the inflammation, apoptosis and oxidative stress of cigarette smoke extract (CSE)-induced bronchial epithelial cells, a chronic obstructive pulmonary disease in vitro model, through the formyl peptide receptor 2 (FPR2) receptors and the adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) pathway.
    Yu C; Zhang L
    Bioengineered; 2022 Feb; 13(2):4028-4038. PubMed ID: 35129068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-1258 Regulates Cell Proliferation and Cell Cycle to Inhibit the Progression of Breast Cancer by Targeting E2F1.
    Zhao X
    Biomed Res Int; 2020; 2020():1480819. PubMed ID: 32733928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
    Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
    Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipose derived stem cells promote tumor metastasis in breast Cancer cells by stem cell factor inhibition of miR20b.
    Xu H; Li W; Luo S; Yuan J; Hao L
    Cell Signal; 2019 Oct; 62():109350. PubMed ID: 31254605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.
    Li Y; Cai L; Wang H; Wu P; Gu W; Chen Y; Hao H; Tang K; Yi P; Liu M; Miao S; Ye D
    Oncogene; 2011 Sep; 30(36):3887-99. PubMed ID: 21499310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
    Bi QJ; Men XJ; Han R; Li GL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
    Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
    Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SEC61G promotes breast cancer development and metastasis via modulating glycolysis and is transcriptionally regulated by E2F1.
    Ma J; He Z; Zhang H; Zhang W; Gao S; Ni X
    Cell Death Dis; 2021 May; 12(6):550. PubMed ID: 34039955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA CASC9 activated by STAT3 promotes the invasion of breast cancer and the formation of lymphatic vessels by enhancing H3K27ac-activated SOX4.
    Fan SJ; Cui Y; Li YH; Xu JC; Shen YY; Huang H; Hu ZC
    Kaohsiung J Med Sci; 2022 Sep; 38(9):848-857. PubMed ID: 35860965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2.
    Ni X; Xia T; Zhao Y; Zhou W; Wu N; Liu X; Ding Q; Zha X; Sha J; Wang S
    Cancer Sci; 2014 Jan; 105(1):18-25. PubMed ID: 24164962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin.
    Wang Z; Yang L; Wu P; Li X; Tang Y; Ou X; Zhang Y; Xiao X; Wang J; Tang H
    Mol Cancer; 2022 Jan; 21(1):29. PubMed ID: 35073911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.
    Wang G; Huang Y; Yang F; Tian X; Wang K; Liu L; Fan Y; Li X; Li L; Shi B; Hao Y; Xia C; Nie Q; Xin Y; Shi Z; Ma L; Xu D; Liu C
    Aging (Albany NY); 2020 Feb; 12(3):2030-2048. PubMed ID: 32007952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
    Richter C; Marquardt S; Li F; Spitschak A; Murr N; Edelhäuser BAH; Iliakis G; Pützer BM; Logotheti S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):292. PubMed ID: 31287003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FPR2 enhances colorectal cancer progression by promoting EMT process.
    Lu J; Zhao J; Jia C; Zhou L; Cai Y; Ni J; Ma J; Zheng M; Lu A
    Neoplasma; 2019 Sep; 66(5):785-791. PubMed ID: 31288528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.